To investigate whether UBE2L3 was a driving factor for NSCLC carcinogenesis or not, we then evaluated the biological role of UBE2L3 in NSCLC cells by knocking down or overexpressing UBE2L3. This evidence concerns the gene UBE2L3 and non-small cell lung carcinoma.